Two Million Americans Harbor MRSA Superbug
Dec 22, 2005 - 3:50:00 AM
, Reviewed by: Priya Saxena
|
|
|
Interestingly, carriage of certain strains do seem to vary by sociodemographics, especially age and race. We need to learn more in order to allow design of new, more effective interventions"
|
By The Journal of Infectious Diseases,
[RxPG] New research estimates that about 2 million people carry a strain of drug-resistant bacteria in their noses. The research, conducted by the Centers for Disease Control and Prevention (CDC), is the first reliable nationwide estimate of colonization with Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA). It is published in the Jan. 15 issue of The Journal of Infectious Diseases, now available online.
Those colonized with normal strains of staph are at higher risk of infection with the bacterium, which can lead to conditions ranging from mild skin infections to fatal toxic shock syndrome. MRSA causes more difficult-to-treat and, sometimes, more virulent illnesses. MRSA was once primarily a problem in hospitals, but is now a growing problem in communities around the country.
Matthew J. Kuehnert, MD, and colleagues collected samples from nearly 10,000 participants in the 2001-2002 National Health and Nutritional Examination Survey, a representative sample of the U.S. population.
Nearly one-third were found to be colonized with staph. Prevalence was highest among males and children between 6 and 11 years old. MRSA prevalence was 0.8 percent. MRSA was highest among women and those older than 60, but those colonized with strains commonly associated with community-associated MRSA were more likely to be younger and black.
Overall, strains and toxins previously found to be associated with community-associated MRSA were unusual. The genetic diversity of strains was remarkableabout half of isolates, including MRSA strains, had unique molecular fingerprinting patterns, and some fell outside recognized groups.
"There is a lot about staph colonization we don't know, Dr. Kuehnert said. Interestingly, carriage of certain strains do seem to vary by sociodemographics, especially age and race. We need to learn more in order to allow design of new, more effective interventions," he added, including vaccines or antimicrobial treatment. Data from subsequent survey years may determine whether there are ongoing trends in colonization.
In an accompanying editorial, Clarence Buddy Creech II, MD, of Vanderbilt University and colleagues observe that, In light of the increasing frequency of community-associated MRSA infection, new antimicrobials are needed, although an effective vaccine against staph would provide a more permanent solution.
Publication:
Jan. 15 issue of The Journal of Infectious Diseases
On the web:
www.idsociety.org 
|
Advertise in this space for $10 per month.
Contact us today.
|
 |
|
Subscribe to MRSA Newsletter
|
|
|
|
Additional information about the news article
|
Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. JID is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Alexandria, Va., IDSA is a professional society representing about 8,000 physicians and scientists who specialize in infectious diseases.
|
|
Feedback
|
For any corrections of factual information, to contact the editors or to send
any medical news or health news press releases, use
feedback form
|
Top of Page
|
